Tag: Portable Oxygen Concentrator

LONDON and PLANO, Texas – Belluscura shipped or received orders for 2,850 X-PLOR portable oxygen concentrators by Dec. 31, 2022, the company stated in a trading update for the year.  The company anticipates its adjusted EBITDA loss will be in line with market expectations. Its retained cash balances of $1.8 million amounted to $11.9 million, with inventory and inventory deposits.  "During the year we have made considerable progress,” said CEO Robert Rauker. “We have...

GOLETA, Calif. – Inogen has received 510(k) clearance from the U.S. Food and Drug Administration for its latest portable oxygen concentrator, the Rove 4. The company has already launched the Rove 6, a new and improved six-setting device, in European countries, where reimbursement is grandfathered, and it plans to launch the Rove 4, a four-setting device, in the U.S. by the back half of 2023. Inogen has also received European Medical Device Regulation certification to sell and commercialize...

LONDON and PLANO, Texas – Belluscura has entered into its first international distribution agreement outside of the United States with MedHealth Supplies of South Africa. MedHealth has placed orders for 2022 and 2023, with deliveries starting immediately. “This is a big step in Belluscura’s expansion outside of the U.S.,” said Robert Rauker, CEO of Belluscura. MedHealth’s founders have a long history in the supplemental oxygen space, and we are excited to work...

LONDON and PLANO, Texas – Belluscura has signed a distribution agreement with a leading DME provider and distributor in the United States, it has announced. Belluscura, which makes the X-PLOR portable oxygen concentrator, says the DME provider has been supplying home oxygen therapy for more than 50 years through 1,000 brick-and-mortar locations throughout the country, as well as online. “This agreement, with one of the largest supplemental oxygen providers in the U.S., significantly increased...

LONDON and PLANO, Texas – Belluscura has launched its next-generation X-PLOR portable oxygen concentrator (formerly described as X-PLOR CX) with Nomad Health App. Bluetooth capabilities allow patients to connect their X-PLOR to other smart devices, such as their iPhone or Android phone, their Nonin or Masimo pulse oximeters and their Fitbit wearables, helping them to track oxygen use, breathing rates, blood oxygen saturation levels, heart rate, sleep and other important biometric and environmental...

GOLETA, Calif. – Inogen reported total revenues of $103.4 million for the second quarter of 2022, a 1.8% increase compared to the same period in 2021 and a 28.6% increase compared to the prior quarter.  “We delivered solid performance in the quarter driven by our ability to fulfill customer demand, while effectively managing supply chain challenges and macro headwinds,” said Nabil Shabshab, Inogen’s president and CEO.  Other financial results:  Adjusted...

IGOLETA, Calif. – Inogen reported total revenue of $80.4 million for the first quarter of 2022, down 7.5% from the same period in 2021, primarily due to supply chain constraints.  The company says, however, that total revenue was up 5.2% sequentially from the fourth quarter of 2021.  Inogen reported revenue of $34.4 million for its domestic direct-to-consumer channel, up 12.2%; and revenue of $5.1 million for its domestic business-to-business channel, down 83.4%. It reported...

DENVER – ARYA BioMed Corp. has entered the home oxygen therapy market with a portable oxygen concentrator. The company says its POC weighs only five pounds with an eight-cell battery and only six pounds with a 16-cell battery. It features pulse-flow settings ranging from 1-5, a battery life of up to eight hours with the standard eight-cell battery pack, a sensitive breath detection, an auto-dose safety feature and more. It has also been approved by the U.S. Food and Drug Administration for...

NEW YORK – HME providers expect to shift an average of 58.4% of their Philips Respironics flow generator purchases and an average of 30.2% of their mask purchases to other companies due to the recall, according to the first quarter HME Sleep and Oxygen Survey from Needham.  That’s up from the 56% and 23.1%, respectively, reported in the third quarter survey.  “ResMed should gain market share over the (next 12 months),” the survey states. “Respondents...

LONDON and PLANO, Texas – Belluscura’s X-PLOR portable oxygen concentrator has been awarded a distribution and pricing agreement from the U.S. Defense Logistics Agency (DLA) through its distribution partner, Lovell Government Services.  DLA procures more than $41.8 billion in goods and services annually from manufacturers and suppliers and provides them to the Department of Defense and other federal/state customers throughout the U.S. and globally.  “Receiving the...